The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia.

MLA

Karantanos, Theodoros, et al. “The Role of the Atypical Chemokine Receptor CCRL2 in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia.” Science Advances, vol. 8, no. 7, Feb. 2022, p. eabl8952. EBSCOhost, https://doi.org/10.1126/sciadv.abl8952.

APA

Karantanos, T., Teodorescu, P., Perkins, B., Christodoulou, I., Esteb, C., Varadhan, R., Helmenstine, E., Rajkhowa, T., Paun, B. C., Bonifant, C., Dalton, W. B., Gondek, L. P., Moliterno, A. R., Levis, M. J., Ghiaur, G., & Jones, R. J. (2022). The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia. Science Advances, 8(7), eabl8952. https://doi.org/10.1126/sciadv.abl8952

Chicago

Karantanos, Theodoros, Patric Teodorescu, Brandy Perkins, Ilias Christodoulou, Christopher Esteb, Ravi Varadhan, Eric Helmenstine, et al. 2022. “The Role of the Atypical Chemokine Receptor CCRL2 in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia.” Science Advances 8 (7): eabl8952. doi:10.1126/sciadv.abl8952.